KalVista Pharmaceuticals, Inc. short interest in 2023
In 2023, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 8.69% of shares outstanding on 13 Jan 2023 to 10.67% on 29 Dec 2023, a change of +1.98 percentage points. The year's high was 13.48% on 13 Oct 2023 and its low 7.20% on 15 Mar 2023, averaging 10.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 35.14 days on 31 Jul 2023. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 8.69% (13 Jan 2023)
- End of year
- 10.67% (29 Dec 2023)
- Change
- +1.98 pp
- High
- 13.48% (13 Oct 2023)
- Low
- 7.20% (15 Mar 2023)
- Average
- 10.62%
- Highest days to cover
- 35.14 (31 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 8.69% | 6.74 | |
| 31 Jan 2023 | 11.00% | 5.42 | |
| 15 Feb 2023 | 10.98% | 9.55 | |
| 28 Feb 2023 | 8.83% | 5.48 | |
| 15 Mar 2023 | 7.20% | 8.87 | 10-Q filed, results (8-K) |
| 31 Mar 2023 | 7.92% | 8.84 | |
| 14 Apr 2023 | 8.20% | 12.66 | |
| 28 Apr 2023 | 9.60% | 14.53 | |
| 15 May 2023 | 10.02% | 15.67 | |
| 31 May 2023 | 10.51% | 16.00 | |
| 15 Jun 2023 | 10.93% | 20.37 | |
| 30 Jun 2023 | 10.97% | 20.55 | |
| 14 Jul 2023 | 11.40% | 23.54 | 10-K filed, results (8-K) |
| 31 Jul 2023 | 11.65% | 35.14 | |
| 15 Aug 2023 | 11.96% | 15.31 | |
| 31 Aug 2023 | 11.28% | 15.59 | |
| 15 Sep 2023 | 11.81% | 15.60 | 10-Q filed, results (8-K) |
| 29 Sep 2023 | 12.88% | 19.56 | |
| 13 Oct 2023 | 13.48% | 9.57 | |
| 31 Oct 2023 | 12.03% | 20.40 | |
| 15 Nov 2023 | 11.64% | 12.69 | |
| 30 Nov 2023 | 11.17% | 16.29 | |
| 15 Dec 2023 | 10.09% | 8.42 | 10-Q filed, results (8-K) |
| 29 Dec 2023 | 10.67% | 9.51 |
See also: KalVista Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.